Related Experiment Video

Updated: May 30, 2026

The Specification of Telencephalic Glutamatergic Neurons from Human Pluripotent Stem Cells
10:49

The Specification of Telencephalic Glutamatergic Neurons from Human Pluripotent Stem Cells

Published on: April 14, 2013

Neuronal maturation defect in induced pluripotent stem cells from patients with Rett syndrome

Kun-Yong Kim1, Eriona Hysolli, In-Hyun Park

  • 1Department of Genetics, Yale Stem Cell Center, Yale School of Medicine, New Haven, CT 06520, USA.

Proceedings of the National Academy of Sciences of the United States of America
|August 3, 2011
PubMed

Insights

Researchers developed a new in vitro model for Rett syndrome (RTT), a neurodevelopmental disorder. This model uses induced pluripotent stem cells (iPSCs) to study RTT's cellular mechanisms and potential therapies.

Area of Science:

  • Neuroscience
  • Genetics
  • Developmental Biology

Background:

  • Rett syndrome (RTT) is a leading neurodevelopmental disorder affecting females, primarily caused by mutations in the methyl CpG binding protein 2 (MeCP2) gene.
  • Classical RTT patients show typical development until 6-18 months, followed by regression in language, motor skills, and purposeful hand movements.

Purpose of the Study:

  • To create a novel in vitro human model for studying Rett syndrome.
  • To investigate the cellular and molecular mechanisms underlying RTT using patient-derived cells.

Main Methods:

  • Generated induced pluripotent stem cells (iPSCs) from RTT patient fibroblasts by overexpressing OCT4, SOX2, KLF4, and MYC.
  • Isolated iPSCs with varying X chromosome inactivation states, including those expressing mutant or wild-type (WT) MeCP2.
  • Differentiated iPSCs into neurons to assess RTT-related phenotypes.

Main Results:

  • Successfully generated iPSCs from RTT fibroblasts, with some maintaining X chromosome inactivation and others showing reactivation.
  • Identified iPSCs expressing either mutant or WT MeCP2, or both, reflecting different disease states.
  • Demonstrated that mutant RTT-iPSCs exhibited impaired neuronal maturation, consistent with RTT phenotypes.

Conclusions:

  • The developed in vitro RTT model using iPSCs is a valuable tool for understanding RTT pathophysiology.
  • This model facilitates further research into RTT and the development of potential therapeutic strategies.

More Related Videos

Generation of Retinal Organoids from Healthy and Retinal Disease-Specific Human-Induced Pluripotent Stem Cells09:47

Generation of Retinal Organoids from Healthy and Retinal Disease-Specific Human-Induced Pluripotent Stem Cells

Published on: December 9, 2022

A Guide to Generating and Using hiPSC Derived NPCs for the Study of Neurological Diseases09:30

A Guide to Generating and Using hiPSC Derived NPCs for the Study of Neurological Diseases

Published on: February 21, 2015

Related Concept Videos

Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...